Compounds > ornithylaspartate
Page last updated: 2024-08-22

ornithylaspartate and Liver Diseases

ornithylaspartate has been researched along with Liver Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, L; Jiang, Y; Mao, Q; Wang, J; Wang, X; Wang, Y; Xiang, DD; Yan, Z; Zhang, X1
Häussinger, D; Wettstein, M1
Koczorek, M1

Reviews

1 review(s) available for ornithylaspartate and Liver Diseases

ArticleYear
[Hepatic encephalopathy--therapy].
    Deutsche medizinische Wochenschrift (1946), 2003, Dec-12, Volume: 128, Issue:50

    Topics: Administration, Oral; Ammonia; Anti-Bacterial Agents; Diet, Protein-Restricted; Dipeptides; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Humans; Liver Diseases

2003

Other Studies

2 other study(ies) available for ornithylaspartate and Liver Diseases

ArticleYear
[Effect of L-ornithine L-aspartate granules in treating chronic liver disease in patients with high-level serum gamma-glutamyltransferase].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2014, Volume: 22, Issue:7

    Topics: Chronic Disease; Dipeptides; gamma-Glutamyltransferase; Humans; Liver Diseases; Liver Function Tests

2014
[Chronic liver diseases. The nihilism has gone].
    MMW Fortschritte der Medizin, 2001, Dec-13, Volume: 143, Issue:51-52

    Topics: Amantadine; Antioxidants; Antiviral Agents; Chronic Disease; Dipeptides; Drug Therapy, Combination; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Diseases; Pentoxifylline; Phosphodiesterase Inhibitors; Prospective Studies; Protective Agents; Ribavirin; Silymarin

2001